Dr. Peter C. Albertsen This is Me
View Title...
University of Connecticut Health Center
Farmington, Connecticut
Please Note:
This profile was automatically generated using 257 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 257 references found on the Internet. This information has not been verified. Learn more...
Employment History
View...Board Membership and Affiliations
View...View all 257 references Web References
-
1. NEAUA - Urology Programs
www.neaua.org/urologyPrograms. - [Cached]Published on: 4/2/2008 Last Visited: 4/2/2008
Peter C. Albertsen, MD 860-679-3676 -
2. www.nursesworldmag.com
www.nursesworldmag.com/health- - [Cached]Published on: 1/17/2008 Last Visited: 2/15/2008
"To me, this is a nightmare," said Dr. Peter C. Albertson, a surgery professor and prostate cancer specialist at the University of Connecticut. "We are just feeding off of this cancer phobia."
"We plan to offer the test now because we believe that some men and their physicians will want to take advantage of these findings -- knowing the test will be refined over time," Xu said. He said that the data used in the study focused on Swedish men, and further study is needed with different racial and ethnic groups. -
3. www.phn-online.com
www.phn-online.com/contents/Ne - [Cached]Published on: 2/15/2008 Last Visited: 2/15/2008
Dr. Peter Albertsen, a urologist at the University of Connecticut in Farmington and author of an editorial accompanying the journal article, says Newschaffer's study should give proponents of the PSA test pause. "You've got to be careful before you declare victory that PSA has been proven" effective, says Albertsen.
At the same time, he notes, the margin of error could mean that prostate deaths are even less common than believed and the screening technique is a success. Since prostate tumors typically grow so slowly, doctors won't know for sure about the efficacy of PSA testing for roughly five more years, he adds.
...
SOURCES: Interviews with Craig Newschaffer, Ph.D., department of epidemiology, Johns Hopkins School of Public Health, Baltimore; Peter Albertsen, M.D., professor and chief of urology, University of Connecticut Health Center, Farmington; and Ruth Etzioni, Ph.D., associate member, Fred Hutchinson Cancer Research Center, Seattle; April 19, 2000 Journal of the National Cancer Institute
